Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research focused on Priming (agriculture) and Gastroesophageal Junction, with related work in Cancer, Cytotoxic T cell, Antibody-drug conjugate. Notable publications include 'β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8 + T cells through regulation of IL-10', 'β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells', and 'CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial'.
CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
Safety and preliminary efficacy of ATG-022 in patients with advanced/metastatic gastric cancer (CLINCH).
Preliminary efficacy and safety of TT-01488, a novel, non-covalent, reversible BTK inhibitor, in patients with relapsed/refractory mantle cell lymphoma
β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8<sup>+</sup>T cells through regulation of IL-10
β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells